The role of the periaqueductal gray in the modulation of pain in males and females: Are the anatomy and physiology really that different?

Neural Plasticity

Volumn 2009, Issue , 2009, Pages

  Loyd, Dayan R ^a   Murphy, Anne Z ^a  

^a GEORGIA STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MORPHINE; PROTEIN FOS; SEX HORMONE; NARCOTIC ANALGESIC AGENT;

ANALGESIA; ANATOMICAL VARIATION; ANTINOCICEPTION; DRUG POTENCY; HUMAN; INFLAMMATION; NEUROANATOMY; NEUROMODULATION; NONHUMAN; PAIN; PERIAQUEDUCTAL GRAY MATTER; REVIEW; SEX DIFFERENCE; SPINAL CORD DORSAL HORN; ANIMAL; CAT; DRUG EFFECT; DRUG TOLERANCE; FEMALE; MALE; MEDULLA OBLONGATA; NERVE TRACT; PATHOPHYSIOLOGY; PHYSIOLOGY; POSTERIOR HORN CELL; PRIMATE; RABBIT; RAT; SEXUAL DEVELOPMENT;

ANALGESICS, OPIOID; ANIMALS; CATS; DRUG TOLERANCE; FEMALE; GONADAL HORMONES; MALE; MEDULLA OBLONGATA; MORPHINE; NEURAL PATHWAYS; PAIN; PERIAQUEDUCTAL GRAY; POSTERIOR HORN CELLS; PRIMATES; RABBITS; RATS; SEX CHARACTERISTICS;

EID: 60849095554     PISSN: 20905904     EISSN: None     Source Type: Journal    
DOI: 10.1155/2009/462879     Document Type: Review

References (141)

1. D. V. Reynolds, "Surgery in the rat during electrical analgesia induced by focal brain stimulation," Science, vol. 164, no. 3878, pp. 444-445, 1969.
2. A. J. Beitz, R. D. Shepard, and W. E. Wells, "The periaqueductal gray-raphe magnus projection contains somatostatin, neurotensin and serotonin but not cholecystokinin," Brain Research, vol. 261, no. 1, pp. 132-137, 1983.
3. A. J. Beitz and R. D. Shepard, "The midbrain periaqueductal gray in the rat. II. A Golgi analysis," The Journal of Comparative Neurology, vol. 237, no. 4, pp. 460-475, 1985.
4. A. J. Beitz, "The midbrain periaqueductal gray in the rat. I. Nuclear volume, cell number, density, orientation, and regional subdivisions," The Journal of ComparativeNeurology, vol. 237, no. 4, pp. 445-459, 1985.
5. A. J. Beitz, "The organization of afferent projections to the midbrain periaqueductal gray of the rat," Neuroscience, vol. 7, no. 1, pp. 133-159, 1982.
6. A. I. Basbaum and H. L. Fields, "Endogenous pain control mechanisms: Review and hypothesis," Annals of Neurology, vol. 4, no. 5, pp. 451-462, 1978.
7. M. M. Behbehani and H. L. Fields, "Evidence that an excitatory connection between the periaqueductal gray and nucleus raphe magnus mediates stimulation produced analgesia," Brain Research, vol. 170, no. 1, pp. 85-93, 1979.
8. F. G. Williams, M. A. Mullet, and A. J. Beitz, "Basal release of Met-enkephalin and neurotensin in the ventrolateral periaqueductal gray matter of the rat: A microdialysis study of antinociceptive circuits," Brain Research, vol. 690, no. 2, pp. 207-216, 1995.
9. S. L. Jones and A. R. Light, "Serotoninergic medullary raphespinal projection to the lumbar spinal cord in the rat: A retrograde immunohistochemical study," The Journal of Comparative Neurology, vol. 322, no. 4, pp. 599-610, 1992.
10. L. J. Mouton and G. Holstege, "Segmental and laminar organization of the spinal neurons projecting to the periaqueductal gray (PAG) in the cat suggests the existence of at least five separate clusters of spino-PAG neurons," The Journal of Comparative Neurology, vol. 428, no. 3, pp. 389-410, 2000.
11. V. G. J.M. Vanderhorst, L. J.Mouton, B. F. M. Blok, and G. Holstege, "Distinct cell groups in the lumbosacral cord of the cat project to different areas in the periaqueductal gray," The Journal of Comparative Neurology, vol. 376, no. 3, pp. 361-385, 1996.
12. V. G. J. M. Vanderhorst, F. C. Schasfoort, E. Meijer, F. W. Van Leeuwen, and G. Holstege, "Estrogen receptor-alphaimmunoreactive neurons in the periaqueductal gray of the adult ovariectomized female cat," Neuroscience Letters, vol. 240, no. 1, pp. 13-16, 1998.
13. G. Holstege and R. J. Cowie, "Projections from the rostral mesencephalic reticular formation to the spinal cord. An HRP and autoradiographical tracing study in the cat," Experimental Brain Research, vol. 75, no. 2, pp. 265-279, 1989.
14. I. A. Abols and A. I. Basbaum, "A.erent connections of the rostral medulla of the cat: A neural substrate for midbrainmedullary interactions in the modulation of pain," The Journal of Comparative Neurology, vol. 201, no. 2, pp. 285-297, 1981.
15. J. Sandkuhler, Q.-G. Fu, and M. Zimmermann, "Spinal pathways mediating tonic or stimulation-produced descending inhibition from the periaqueductal gray or nucleus raphe magnus are separate in the cat," Journal of Neurophysiology, vol. 58, no. 2, pp. 327-341, 1987.
16. J. Sandkuhler, B. Maisch, and M. Zimmermann, "Raphe magnus-induced descending inhibition of spinal nociceptive neurons is mediated through contralateral spinal pathways in the cat," Neuroscience Letters, vol. 76, no. 2, pp. 168-172, 1987.
17. Y. Shah and J. O. Dostrovsky, "Electrophysiological evidence for a projection of the periaqueductal gray matter to nucleus raphe magnus in cat and rat," Brain Research, vol. 193, no. 2, pp. 534-538, 1980.
18. A. I. Basbaum, C. H. Clanton, and H. L. Fields, "Three bulbospinal pathways from the rostral medulla of the cat: An autoradiographic study of pain modulating systems," The Journal of Comparative Neurology, vol. 178, no. 2, pp. 209-224, 1978.
19. P.W.Mantyh, "Connections of midbrain periaqueductal gray in themonkey. II. Descending efferent projections," Journal of Neurophysiology, vol. 49, no. 3, pp. 582-594, 1983.
20. K. D. Gerhart, R. P. Yezierski, T. K. Wilcox, and W. D. Willis, "Inhibition of primate spinothalamic tract neurons by stimulation in periaqueductal gray of adjacent midbrain reticular formation," Journal of Neurophysiology, vol. 51, no. 3, pp. 450-466, 1984.
21. J. R.Haselton, R.W.Winters, D. R. Liskowsky, C. L.Haselton, P. M. McCabe, and N. Schneiderman, "Anatomical and functional connections of neurons of the rostral medullary raphe of the rabbit," Brain Research, vol. 453, no. 1-2, pp. 176-182, 1988.
22. A. I. Basbaum and H. L. Fields, "Endogenous pain control systems: brainstemspinal pathways and endorphin circuitry," Annual Review of Neuroscience, vol. 7, pp. 309-338, 1984.
23. T. L. Yaksh and T. A. Rudy, "Narcotic analgetics: CNS sites and mechanisms of action as revealed by intracerebral injection techniques," Pain, vol. 4, no. 4, pp. 299-359, 1978.
24. Z.-F. Cheng, H. L. Fields, and M. M. Heinricher, "Morphine microinjected into the periaqueductal gray has differential effects on 3 classes of medullary neurons," Brain Research, vol. 375, no. 1, pp. 57-65, 1986.
25. M. M. Morgan, M. M. Heinricher, and H. L. Fields, "Circuitry linking opioid-sensitive nociceptive modulatory systems in periaqueductal gray and spinal cord with rostral ventromedial medulla," Neuroscience, vol. 47, no. 4, pp. 863-871, 1992.
26. D. A. Lane, P. A. Patel, and M. M. Morgan, "Evidence for an intrinsic mechanism of antinociceptive tolerance within the ventrolateral periaqueductal gray of rats," Neuroscience, vol. 135, no. 1, pp. 227-234, 2005.
27. R. E. Wilcox, J. A. Mikula, and R. A. Levitt, "Periaqueductal gray naloxone microinjections in morphine-dependent rats: Hyperalgesia without "classical" withdrawal," Neuropharmacology, vol. 18, no. 7, pp. 639-641, 1979.
28. Q. P.Ma and J. S. Han, "Naloxone blocks the release of opioid peptides in periaqueductal gray and N. accumbens induced by intra-amygdaloid injection of morphine," Peptides, vol. 12, no. 6, pp. 1235-1238, 1991.
29. Y. Zhang, L.-N. Du, G.-C. Wu, and X.-D. Cao, "Modulation of intrathecal morphine-induced immunosuppression by microinjection of naloxone into periaqueductal gray," Zhongguo Yao Li Xue Bao, vol. 19, no. 6, pp. 519-522, 1998.
30. V. A. Lewis and G. F. Gebhart, "Evaluation of the periaqueductal central gray (PAG) as a morphine specific locus of action and examination of morphine induced and stimulation produced analgesia at coincident PAG loci," Brain Research, vol. 124, no. 2, pp. 283-303, 1977.
31. A.Mansour,H. Khachaturian, M. E. Lewis, H. Akil, and S. J. Watson, "Autoradiographic di.erentiation of mu, delta, and kappa opioid receptors in the rat forebrain and midbrain," The Journal of Neuroscience, vol. 7, no. 8, pp. 2445-2464, 1987.
32. A. Mansour, M. E. Lewis, H. Khachaturian, H. Akil, and S. J. Watson, "Pharmacological and anatomical evidence of selective ì, ä, and ö, opioid receptor binding in rat brain," Brain Research, vol. 399, no. 1, pp. 69-79, 1986.
33. H. B. Gutstein, A. Mansour, S. J. Watson, H. Akil, and H. L. Fields, "Mu and kappa opioid receptors in periaqueductal gray and rostral ventromedial medulla," NeuroReport, vol. 9, no. 8, pp. 1777-1781, 1998.
34. A. E. Kalyuzhny, U. Arvidsson, W. Wu, and M. W. Wessendorf, "ì-opioid and ä-opioid receptors are expressed in brainstem antinociceptive circuits: Studies using immunocytochemistry and retrograde tract-tracing," The Journal of Neuroscience, vol. 16, no. 20, pp. 6490-6503, 1996.
35. K. G. Commons, S. A. Aicher, L.-M. Kow, and D. W. Pfa., "Presynaptic and postsynaptic relations of ì-opioid receptors to ã-aminobutyric acid-immunoreactive and medullaryprojecting periaqueductal gray neurons," The Journal of Comparative Neurology, vol. 419, no. 4, pp. 532-542, 2000.
36. K. G. Commons, E. J. Van Bockstaele, and D. W. Pfa., "Frequent colocalization of mu opioid and NMDA-type glutamate receptors at postsynaptic sites in periaqueductal gray neurons," The Journal of Comparative Neurology, vol. 408, no. 4, pp. 549-559, 1999.
37. H. Wang and M. W. Wessendorf, "ì- and ä-opioid receptor mRNAs are expressed in periaqueductal gray neurons projecting to the rostral ventromedial medulla," Neuroscience, vol. 109, no. 3, pp. 619-634, 2002.
38. D. R. Loyd, X.Wang, and A. Z.Murphy, "Sex di.erences in ì- opioid receptor expression in the rat midbrain periaqueductal gray are essential for eliciting sex differences in morphine analgesia," The Journal of Neuroscience, vol. 28, no. 52, pp. 14007-14017, 2008.
39. K. L. Kepler, K. M. Standifer, D. Paul, B. Kest, G. W. Pasternak, and R. J. Bodnar, "Gender effects and central opioid analgesia," Pain, vol. 45, no. 1, pp. 87-94, 1991.
40. K. L. Kepler, B. Kest, J. M. Kiefel, M. L. Cooper, and R. J. Bodnar, "Roles of gender, gonadectomy and estrous phase in the analgesic effects of intracerebroventricular morphine in rats," Pharmacology Biochemistry and Behavior, vol. 34, no. 1, pp. 119-127, 1989.
41. A. I. Baamonde, A. Hidalgo, and F. Andres-Trelles, "Sexrelated di.erences in the effects of morphine and stress on visceral pain," Neuropharmacology, vol. 28, no. 9, pp. 967-970, 1989.
42. M. Kavaliers and D. G. L. Innes, "Sex and day-night differences in opiate-induced responses of insular wild deer mice, Peromyscus maniculatus triangularis," Pharmacology Biochemistry and Behavior, vol. 27, no. 3, pp. 477-482, 1987.
43. K. Okamoto, A. Tashiro, H. Hirata, and D. A. Bereiter, "Differential modulation of TMJ neurons in superficial laminae of trigeminal subnucleus caudalis/upper cervical cord junction region of male and cycling female rats by morphine," Pain, vol. 114, no. 1-2, pp. 203-211, 2005.
44. Y. Ji, A. Z. Murphy, and R. J. Traub, "Estrogen modulation of morphine analgesia of visceral pain in female rats is supraspinally and peripherally mediated," The Journal of Pain, vol. 8, no. 6, pp. 494-502, 2007.
45. Y. Ji, A. Z. Murphy, and R. J. Traub, "Sex di.erences in morphine-induced analgesia of visceral pain are supraspinally and peripherally mediated," American Journal of Physiology, vol. 291, no. 2, pp. R307-R314, 2006.
46. X. Wang, R. J. Traub, and A. Z. Murphy, "Persistent pain model reveals sex difference in morphine potency," American Journal of Physiology, vol. 291, no. 2, pp. R300-R306, 2006.
47. A. C. Barrett, C. D. Cook, J. M. Terner, R. M. Craft, and M. J. Picker, "Importance of sex and relative efficacy at the μ opioid receptor in the development of tolerance and cross-tolerance to the antinociceptive effects of opioids," Psychopharmacology, vol. 158, no. 2, pp. 154-164, 2001.
48. R. E. Bartok and R. M. Craft, "Sex differences in opioid antinociception," Journal of Pharmacology and Experimental Therapeutics, vol. 282, no. 2, pp. 769-778, 1997.
49. J. S. Boyer, M. M. Morgan, and R. M. Craft, "Microinjection of morphine into the rostral ventromedial medulla produces greater antinociception in male compared to female rats," Brain Research, vol. 796, no. 1-2, pp. 315-318, 1998.
50. T. J.Cicero, B. Nock, and E. R.Meyer, "Sex-related differences in morphine's antinociceptive activity: Relationship to serum and brain morphine concentrations," Journal of Pharmacology and Experimental Therapeutics, vol. 282, no. 2, pp. 939-944, 1997.
51. B. Kest, S. G. Wilson, and J. S. Mogil, "Sex differences in supraspinalmorphine analgesia are dependent on genotype," Journal of Pharmacology and Experimental Therapeutics, vol. 289, no. 3, pp. 1370-1375, 1999.
52. C. D. Cook and M. D. Nickerson, "Nociceptive sensitivity and opioid antinociception and antihyperalgesia in Freund's adjuvant-induced arthritic male and female rats," Journal of Pharmacology and Experimental Therapeutics, vol. 313, no. 1, pp. 449-459, 2005.
53. P. L. Miller and A. A. Ernst, "Sex di.erences in analgesia: A randomized trial of μ versus κ opioid agonists," Southern Medical Journal, vol. 97, no. 1, pp. 35-41, 2004.
54. M. S. Cepeda, J. M. Africano, A. M. Manrique, W. Fragoso, and D. B. Carr, "The combination of low dose of naloxone andmorphine in PCA does not decrease opioid requirements in the postoperative period," Pain, vol. 96, no. 1-2, pp. 73-79, 2002.
55. M. S. Cepeda and D. B. Carr, "Women experience more pain and require more morphine than men to achieve a similar degree of analgesia," Anesthesia and Analgesia, vol. 97, no. 5, pp. 1464-1468, 2003.
56. E. Sarton, E. Olofsen, R. Romberg, et al., "Sex di.erences in morphine analgesia: An experimental study in healthy volunteers," Anesthesiology, vol. 93, no. 5, pp. 1245-1254, 2000, discussion 6A.
57. R. B. Fillingim, T. J. Ness, T. L. Glover, et al., "Morphine responses and experimental pain: Sex differences in side effects and cardiovascular responses but not analgesia," The Journal of Pain, vol. 6, no. 2, pp. 116-124, 2005.
58. N. C. Gordon, R. W. Gear, P. H. Heller, S. Paul, C. Miaskowski, and J. D. Levine, "Enhancement of morphine analgesia by the GABA(B) agonist baclofen," Neuroscience, vol. 69, no. 2, pp. 345-349, 1995.
59. C. Miaskowski, R. W. Gear, and J. D. Levine, "Sex related di.erences in analgesic responses," in Sex, Gender, and Pain, R. B. Fillingim, Ed., pp. 209-232, IASP Press, Seattle, Wash, USA, 2000.
60. M. S. Cepeda, J. T. Farrar, M. Baumgarten, R. Boston, D. B. Carr, and B. L. Strom, "Side effects of opioids during shortterm administration: effect of age, gender, and race," Clinical Pharmacology and Therapeutics, vol. 74, no. 2, pp. 102-112, 2003.
61. B. Kest, E. Sarton, and A. Dahan, "Gender differences in opioid-mediated analgesia: Animal and human studies," Anesthesiology, vol. 93, no. 2, pp. 539-547, 2000.
62. R. M. Craft, "Sex differences in opioid analgesia: "from mouse to man"," Clinical Journal of Pain, vol. 19, no. 3, pp. 175-186, 2003.
63. R. B. Fillingim and R. W. Gear, "Sex differences in opioid analgesia: Clinical and experimental findings," European Journal of Pain, vol. 8, no. 5, pp. 413-425, 2004.
64. A. Dahan, B. Kest, A. R.Waxman, and E. Sarton, "Sex-specific responses to opiates: Animal and human studies," Anesthesia & Analgesia, vol. 107, no. 1, pp. 83-95, 2008.
65. A. C. Barrett, E. S. Smith, and M. J. Picker, "Capsaicininduced hyperalgesia and μ-opioid-induced antihyperalgesia in male and female Fischer 344 rats," Journal of Pharmacology and Experimental Therapeutics, vol. 307, no. 1, pp. 237-245, 2003.
66. L. A. Rosseland and A. Stubhaug, "Gender is a confounding factor in pain trials: Women report more pain than men after arthroscopic surgery," Pain, vol. 112, no. 3, pp. 248-253, 2004.
67. F. Aubrun, N. Salvi, P. Coriat, and B. Riou, "Sex- and agerelated differences in morphine requirements for postoperative pain relief," Anesthesiology, vol. 103, no. 1, pp. 156-160, 2005.
68. R. Cogan and J. A. Spinnato, "Pain and discomfort thresholds in late pregnancy," Pain, vol. 27, no. 1, pp. 63-68, 1986.
69. B. Hellström and U. M. Anderberg, "Pain perception across the menstrual cycle phases in women with chronic pain," Perceptual and Motor Skills, vol. 96, no. 1, pp. 201-211, 2003.
70. M. L. LaCroix-Fralish, V. L. Tawfik, and J. A. DeLeo, "The organizational and activational e.ects of sex hormones on tactile and thermal hypersensitivity following lumbar nerve root injury in male and female rats," Pain, vol. 114, no. 1-2, pp. 71-80, 2005.
71. I. Gaumond, P. Arsenault, and S. Marchand, "The role of sex hormones on formalin-induced nociceptive responses," Brain Research, vol. 958, no. 1, pp. 139-145, 2002.
72. A. M. Aloisi, I. Ceccarelli, P. Fiorenzani, A. M. De Padova, and C. Massafra, "Testosterone affects formalin-induced responses differently in male and female rats," Neuroscience Letters, vol. 361, no. 1-3, pp. 262-264, 2004.
73. J. S. Mogil, E. J. Chesler, S. G. Wilson, J. M. Juraska, and W. F. Sternberg, "Sex differences in thermal nociception and morphine antinociception in rodents depend on genotype," Neuroscience and Biobehavioral Reviews, vol. 24, no. 3, pp. 375-389, 2000.
74. J. M. Tall and T. Crisp, "Effects of gender and gonadal hormones on nociceptive responses to intraplantar carrageenan in the rat," Neuroscience Letters, vol. 354, no. 3, pp. 239-241, 2004.
75. J. M. Tall, S. L. Stuesse, W. L. R. Cruce, and T. Crisp, "Gender and the behavioral manifestations of neuropathic pain," Pharmacology Biochemistry and Behavior, vol. 68, no. 1, pp. 99-104, 2001.
76. A. R. Gintzler, "Endorphin-mediated increases in pain threshold during pregnancy," Science, vol. 210, no. 4466, pp. 193-195, 1980.
77. A. M. Aloisi and I. Ceccarelli, "Role of gonadal hormones in formalin-induced pain responses ofmale rats: Modulation by estradiol and naloxone administration," Neuroscience, vol. 95, no. 2, pp. 559-566, 1999.
78. L. LeResche, L. Mancl, J. J. Sherman, B. Gandara, and S. F. Dworkin, "Changes in temporomandibular pain and other symptoms across the menstrual cycle," Pain, vol. 106, no. 3, pp. 253-261, 2003.
79. A. Korszun, E. A. Young, N. C. Engleberg, et al., "Follicular phase hypothalamic-pituitary-gonadal axis function in women with fibromyalgia and chronic fatigue syndrome," Journal of Rheumatology, vol. 27, no. 6, pp. 1526-1530, 2000.
80. A. J. Beitz, "The sites of origin brain stem neurotensin and serotonin projections to the rodent nucleus raphe magnus," The Journal of Neuroscience, vol. 2, no. 7, pp. 829-842, 1982.
81. E. J. van Bockstaele, G. Aston-Jones, V. A. Pieribone, M. Ennis, and M. T. Shipley, "Subregions of the periaqueductal gray topographically innervate the rostral ventral medulla in the rat," The Journal of Comparative Neurology, vol. 309, no. 3, pp. 305-327, 1991.
82. D. R. Loyd and A. Z. Murphy, "Sex differences in the anatomical and functional organization of the periaqueductal gray-rostral ventromedial medullary pathway in the rat: A potential circuit mediating the sexually dimorphic actions of morphine," The Journal of Comparative Neurology, vol. 496, no. 5, pp. 723-738, 2006.
83. D. R. Loyd, M. M. Morgan, and A. Z. Murphy, "Sexually dimorphic activation of the periaqueductal gray-rostral ventromedial medullary circuit during the development of tolerance to morphine in the rat," European Journal of Neuroscience, vol. 27, no. 6, pp. 1517-1524, 2008.
84. D. R. Loyd, M. M. Morgan, and A. Z. Murphy, "Morphine preferentially activates the periaqueductal gray-rostral ventromedial medullary pathway in the male rat: A potential mechanism for sex differences in antinociception," Neuroscience, vol. 147, no. 2, pp. 456-468, 2007.
85. M. M. Morgan, M. S. Gold, J. C. Liebeskind, and C. Stein, "Periaqueductal gray stimulation produces a spinally mediated, opioid antinociception for the inflamed hindpaw of the rat," Brain Research, vol. 545, no. 1-2, pp. 17-23, 1991.
86. Y. Guan, W. Guo, S.-P. Zou, R. Dubner, and K. Ren, "Inflammation-induced upregulation of AMPA receptor subunit expression in brain stem pain modulatory circuitry," Pain, vol. 104, no. 1-2, pp. 401-413, 2003.
87. K.Miki,Q.-Q. Zhou,W. Guo, et al., "Changes in gene expression and neuronal phenotype in brain stem pain modulatory circuitry after inflammation," Journal of Neurophysiology, vol. 87, no. 2, pp. 750-760, 2002.
88. Y. Guan, R. Terayama, R. Dubner, and K. Ren, "Plasticity in excitatory amino acid receptor-mediated descending pain modulation after inflammation," Journal of Pharmacology and Experimental Therapeutics, vol. 300, no. 2, pp. 513-520, 2002.
89. K. Ren and R. Dubner, "Descending modulation in persistent pain: An update," Pain, vol. 100, no. 1-2, pp. 1-6, 2002.
90. S. L. Jones and G. F. Gebhart, "Inhibition of spinal nociceptive transmission from the midbrain, pons and medulla in the rat: Activation of descending inhibition by morphine, glutamate and electrical stimulation," Brain Research, vol. 460, no. 2, pp. 281-296, 1988.
91. L. D. Aimone, S. L. Jones, and G. F. Gebhart, "Stimulationproduced descending inhibition from the periaqueductal gray and nucleus raphe magnus in the rat: Mediation by spinal monoamines but not opioids," Pain, vol. 31, no. 1, pp. 123-136, 1987.
92. A. J. Waters and B. M. Lumb, "Inhibitory effects evoked from both the lateral and ventrolateral periaqueductal grey are selective for the nociceptive responses of rat dorsal horn neurones," Brain Research, vol. 752, no. 1-2, pp. 239-249, 1997.
93. D. Budai and H. L. Fields, "Endogenous opioid peptides acting at ì-opioid receptors in the dorsal horn contribute to midbrain modulation of spinal nociceptive neurons," Journal of Neurophysiology, vol. 79, no. 2, pp. 677-687, 1998.
94. B. G. Gray and J. O. Dostrovsky, "Descending inhibitory influences from periaqueductal gray, nucleus raphe magnus, and adjacent reticular formation. I. Effects on lumbar spinal cord nociceptive and nonnociceptive neurons," Journal of Neurophysiology, vol. 49, no. 4, pp. 932-947, 1983.
95. E. Carstens, T. Yokota, and M. Zimmermann, "Inhibition of spinal neuronal responses to noxious skin heating by stimulation ofmesencephalic periaqueductal gray in the cat," Journal of Neurophysiology, vol. 42, no. 2, pp. 558-568, 1979.
96. A. C. Barrett, C. D. Cook, J. M. Terner, E. L. Roach, C. Syvanthong, and M. J. Picker, "Sex and rat strain determine sensitivity to ê opioid-induced antinociception," Psychopharmacology, vol. 160, no. 2, pp. 170-181, 2002.
97. K. J. Berkley, "Sex differences in pain," Behavioral and Brain Sciences, vol. 20, no. 3, pp. 371-380, 1997.
98. R. B. Fillingim, "Sex, gender, and pain: Women and men really are different," Current Review of Pain, vol. 4, no. 1, pp. 24-30, 2000.
99. R. B. Fillingim and T. J. Ness, "Sex-related hormonal influences on pain and analgesic responses," Neuroscience and Biobehavioral Reviews, vol. 24, no. 4, pp. 485-501, 2000.
100. D. R. Loyd and A. Z. Murphy, "Anatomical and physiological characterization of the midbrain periaqueductal gray in the female rat: identification of novel pain pathways," Society for Neuroscience, abstract control number 921.3, San Diego, Calif, USA, 2007.
101. C. W. Vaughan, S. L. Ingram, M. A. Connor, and M. J. Christie, "How opioids inhibit GABA-mediated neurotransmission," Nature, vol. 390, no. 6660, pp. 611-614, 1997.
102. B. Chieng and M. J. Christie, "Inhibition by opioids acting on ì-receptors of GABAergic and glutamatergic postsynaptic potentials in single rat periaqueductal gray neurones in vitro," British Journal of Pharmacology, vol. 113, no. 1, pp. 303-309, 1994.
103. B. Chieng and M. J. Christie, "Hyperpolarization by opioids acting on μ-receptors of a sub-population of rat periaqueductal gray neurones in vitro," British Journal of Pharmacology, vol. 113, no. 1, pp. 121-128, 1994.
104. C. W. Vaughan and M. J. Christie, "Presynaptic inhibitory action of opioids on synaptic transmission in the rat periaqueductal grey in vitro," The Journal of Physiology, vol. 498, part 2, pp. 463-472, 1997.
105. P. B. Osborne, C. W. Vaughan, H. I. Wilson, and M. J. Christie, "Opioid inhibition of rat periaqueductal grey neurones with identified projections to rostral ventromedial medulla in vitro," The Journal of Physiology, vol. 490, part 2, pp. 383-389, 1996.
106. M. M. Behbehani, "The role of acetylcholine in the function of the nucleus raphe magnus and in the interaction of this nucleus with the periaqueductal gray," Brain Research, vol. 252, no. 2, pp. 299-307, 1982.
107. M. M. Behbehani, S. L. Pomeroy, and C. E. Mack, "Interaction between central gray and nucleus raphe magnus: Role of norepinephrine," Brain Research Bulletin, vol. 6, no. 5, pp. 361-364, 1981.
108. M. M. Behbehani, "Effect of chronic morphine treatment on the interaction between the periaqueductal grey and the nucleus raphe magnus of the rat," Neuropharmacology, vol. 20, no. 6, pp. 581-586, 1981.
109. A. I. Basbaum and H. L. Fields, "The origin of descending pathways in the dorsolateral funiculus of the spinal cord of the cat and rat: further studies on the anatomy of pain modulation," The Journal of Comparative Neurology, vol. 187, no. 3, pp. 513-531, 1979.
110. J.-L. Moreau and H. L. Fields, "Evidence for GABA involvement in midbrain control of medullary neurons that modulate nociceptive transmission," Brain Research, vol. 397, no. 1, pp. 37-46, 1986.
111. M. M. Behbehani, M. R. Jiang, S. D. Chandler, and M. Ennis, "The effect of GABA and its antagonists on midbrain periaqueductal gray neurons in the rat," Pain, vol. 40, no. 2, pp. 195-204, 1990.
112. M. M. Morgan, C. C. Clayton, and D. A. Lane, "Behavioral evidence linking opioid-sensitive GABAergic neurons in the ventrolateral periaqueductal gray to morphine tolerance," Neuroscience, vol. 118, no. 1, pp. 227-232, 2003.
113. E. N. Fossum, A. L.McNeal, S. L. Ingram, andM.M.Morgan, "Sex differences in antinociception following opioid and non-opioid activation of the periaqueductal gray of the rat," Society for Neuroscience, abstract control number 71.17, Washington, DC, USA, 2008.
114. V. Tortorici and M. M. Morgan, "Comparison of morphine and kainic acid microinjections into identical PAG sites on the activity of RVMneurons," Journal of Neurophysiology, vol. 88, no. 4, pp. 1707-1715, 2002.
115. M. M.Morgan, E. N. Fossum, C. S. Levine, and S. L. Ingram, "Antinociceptive tolerance revealed by cumulative intracranial microinjections of morphine into the periaqueductal gray in the rat," Pharmacology Biochemistry and Behavior, vol. 85, no. 1, pp. 214-219, 2006.
116. J. A. Siuciak and C. Advokat, "Tolerance to morphine microinjections in the periaqueductal gray (PAG) induces tolerance to systemic, but not intrathecal morphine," Brain Research, vol. 424, no. 2, pp. 311-319, 1987.
117. Y. F. Jacquet and A. Lajtha, "The periaqueductal gray: Site of morphine analgesia and tolerance as shown by 2-way cross tolerance between systemic and intracerebral injections," Brain Research, vol. 103, no. 3, pp. 501-513, 1976.
118. V. Tortorici, C. S. Robbins, and M. M.Morgan, "Tolerance to the antinociceptive effect of morphine microinjections into the ventral but not lateral-dorsal periaqueductal gray of the rat," Behavioral Neuroscience, vol. 113, no. 4, pp. 833-839, 1999.
119. E. E. Bagley, B. C. H. Chieng, M. J. Christie, and M. Connor, "Opioid tolerance in periaqueductal gray neurons isolated from mice chronically treated with morphine," British Journal of Pharmacology, vol. 146, no. 1, pp. 68-76, 2005.
120. S. P. Hack, C. W. Vaughan, and M. J. Christie, "Modulation of GABA release during morphine withdrawal in midbrain neurons in vitro," Neuropharmacology, vol. 45, no. 5, pp. 575-584, 2003.
121. E. K. Krzanowska, S. Ogawa, D. W. Pfa., and R. J. Bodnar, "Reversal of sex differences in morphine analgesia elicited from the ventrolateral periaqueductal gray in rats by neonatal hormone manipulations," Brain Research, vol. 929, no. 1, pp. 1-9, 2002.
122. T. J. Cicero, B. Nock, L. O'Connor, and E. R. Meyer, "Role of steroids in sex differences in morphine-induced analgesia: Activational and organizational effects," Journal of Pharmacology and Experimental Therapeutics, vol. 300, no. 2, pp. 695-701, 2002.
123. A. Ratka and J. W. Simpkins, "Effects of estradiol and progesterone on the sensitivity to pain and on morphineinduced antinociception in female rats," Hormones and Behavior, vol. 25, no. 2, pp. 217-228, 1991.
124. E. C. Stoffel, C. M. Ulibarri, and R. M. Craft, "Gonadal steroid hormone modulation of nociception, morphine antinociception and reproductive indices in male and female rats," Pain, vol. 103, no. 3, pp. 285-302, 2003.
125. E. C. Sto.el, C. M. Ulibarri, J. E. Folk, K. C. Rice, and R. M. Craft, "Gonadal hormone modulation of mu, kappa, and delta opioid antinociception in male and female rats," The Journal of Pain, vol. 6, no. 4, pp. 261-274, 2005.
126. J. M. Terner, A. C. Barrett, E. Grossell, and M. J. Picker, "Influence of gonadectomy on the antinociceptive effects of opioids in male and female rats," Psychopharmacology, vol. 163, no. 2, pp. 183-193, 2002.
127. J. M. Terner, L. M. Lomas, and M. J. Picker, "Influence of estrous cycle and gonadal hormone depletion on nociception and opioid antinociception in female rats of four strains," The Journal of Pain, vol. 6, no. 6, pp. 372-383, 2005.
128. E. K. Krzanowska and R. J. Bodnar, "Morphine antinociception elicited from the ventrolateral periaqueductal gray is sensitive to sex and gonadectomy differences in rats," Brain Research, vol. 821, no. 1, pp. 224-230, 1999.
129. J. M. Kiefel and R. J. Bodnar, "Roles of gender and gonadectomy in pilocarpine and clonidine analgesia in rats," Pharmacology Biochemistry and Behavior, vol. 41, no. 1, pp. 153-158, 1992.
130. R. M. Craft, J. S. Mogil, and A. M. Aloisi, "Sex differences in pain and analgesia: The role of gonadal hormones," European Journal of Pain, vol. 8, no. 5, pp. 397-411, 2004.
131. S. A. Bernal, M. M. Morgan, and R. M. Craft, "PAG mu opioid receptor activation underlies sex differences in morphine antinociception," Behavioural Brain Research, vol. 177, no. 1, pp. 126-133, 2007.
132. A. Z. Murphy and G. E. Hoffman, "Distribution of gonadal steroid receptor-containing neurons in the preopticperiaqueductal gray-brainstem pathway: A potential circuit for the initiation of male sexual behavior," The Journal of Comparative Neurology, vol. 438, no. 2, pp. 191-212, 2001.
133. J. Boers, P. O. Gerrits, E. Meijer, and G. Holstege, "Estrogen receptor-alpha-immunoreactive neurons in the mesencephalon, pons and medulla oblongata of the female golden hamster," Neuroscience Letters, vol. 267, no. 1, pp. 17-20, 1999.
134. J. C. Turcotte and J. D. Blaustein, "Immunocytochemical localization of midbrain estrogen receptor- and progestin receptor-containing cells in female guinea pigs," The Journal of Comparative Neurology, vol. 328, no. 1, pp. 76-87, 1993.
135. V. G. J. M. Vanderhorst, E. Terasawa, and H. J. Ralston III, "Estrogen receptor-alpha immunoreactive neurons in the ventrolateral periaqueductal gray receive monosynaptic input from the lumbosacral cord in the rhesus monkey," The Journal of Comparative Neurology, vol. 443, no. 1, pp. 27-42, 2002.
136. V. G. J. M. Vanderhorst, E. Terasawa, and H. J. Ralston III, "Projections from estrogen receptor-α immunoreactive neurons in the periaqueductal gray to the lateral medulla oblongata in the rhesus monkey," Neuroscience, vol. 125, no. 1, pp. 243-253, 2004.
137. D. R. Loyd and A. Z. Murphy, "Androgen and estrogen (α) receptor localization on periaqueductal gray neurons projecting to the rostral ventromedial medulla in the male and female rat," Journal of Chemical Neuroanatomy, vol. 36, no. 3-4, pp. 216-226, 2008.
138. M. J. Kelly, J. Qiu, and O. K. Rønnekleiv, "Estrogen modulation of G-protein-coupled receptor activation of potassium channels in the central nervous system," Annals of the New York Academy of Sciences, vol. 1007, pp. 6-16, 2003.
139. C. B. Eckersell, P. Popper, and P. E. Micevych, "Estrogeninduced alteration of ì-opioid receptor immunoreactivity in the medial preoptic nucleus and medial amygdala," The Journal of Neuroscience, vol. 18, no. 10, pp. 3967-3976, 1998.
140. P. E. Micevych, E. F. Rissman, J.-Å. Gustafsson, and K. Sinchak, "Estrogen receptor-α is required for estrogen-induced μ-opioid receptor internalization," Journal of Neuroscience Research, vol. 71, no. 6, pp. 802-810, 2003.
141. E. C. Stoffel, C. M. Ulibarri, and R. M. Craft, "Gonadal steroid hormone modulation of nociception, morphine antinociception and reproductive indices in male and female rats," Pain, vol. 103, no. 3, pp. 285-302, 2003.